About Proteasome subunit beta type-8
Proteasome subunit beta type-8 (PSMB8) is a protein
from Homo sapiens identified by UniProt accession
P28062, 276 residues long.
MolForge cross-references it against 0 known binders and
320 disease associations.
Target properties
| Protein name | Proteasome subunit beta type-8 |
| UniProt accession | P28062 |
| Gene | PSMB8 |
| Organism | Homo sapiens |
| Length | 276 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (3)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (320)
Diseases linked to this target (Open Targets).
- Proteasome disability syndrome · score 0.79
- proteosome-associated autoinflammatory syndrome · score 0.76
- HIV infection · score 0.46
- glioblastoma multiforme · score 0.37
- autoinflammatory syndrome · score 0.34
- breast adenocarcinoma · score 0.30
- esophageal cancer · score 0.28
- urinary bladder cancer · score 0.28
- head and neck squamous cell carcinoma · score 0.28
- squamous cell lung carcinoma · score 0.28
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P28062-F1 | alphafold | PREDICTED | 83.81 | — |
Amino-acid sequence (276 residues)
MALLDVCGAP RGQRPESALP VAGSGRRSDP GHYSFSMRSP ELALPRGMQP TEFFQSLGGD GERNVQIEMA HGTTTLAFKF QHGVIAAVDS RASAGSYISA LRVNKVIEIN PYLLGTMSGC AADCQYWERL LAKECRLYYL RNGERISVSA ASKLLSNMMC QYRGMGLSMG SMICGWDKKG PGLYYVDEHG TRLSGNMFST GSGNTYAYGV MDSGYRPNLS PEEAYDLGRR AIAYATHRDS YSGGVVNMYH MKEDGWVKVE STDVSDLLHQ YREANQ
Explore Proteasome subunit beta type-8 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets